Skip to main content

Table 1 Description of the included studies

From: Increased serum amyloid A as potential diagnostic marker for lung cancer: a meta-analysis based on nine studies

Authors

Year

All cases (control/cancer)

Age (years)

Gender (Male/female) (N)

Histology of lung cancer (N)

Tumor Stage of lung cancer

Control

Lung cancer

Control

Lung cancer

LAC

LSCC

SCLC

Others

Benson MD [12]

1986

100 (50/50)

37 ± 1.9

61.1 ± 1.2

50/0

50/0

5

29

10

NA

I-IV

Howard BA [13]

2003

34 (15/19)

50.7 (23–77)

22/12

17

2

0

NA

Khan N [14]

2004

50 (25/25)

62.9 (46–83)

66.1 (47–87)

16/9

16/9

9

6

NA

8

I-IV

Dai S [16]

2007

218 (43/175)

NA

NA

NA

NA

59

78

38

0

NA

Liu DH [17]

2007

275 (82/194)

NA

65 (41–76)

NA

135/58

65

97

31

0

I-IV

Cho WC [15]

2010

189 (35/154)

NA

65.5 ± 0.9

NA

129/25

50

53

38

13

I-IV

Sung HJ [4]

2011

380 (140/240)

59 (37–84)

57 (32–79)

96/44

217/53

140

50

50

0

I–IV

Dowling P [18]

2011

109 (30/79)

56.5 ± 7

61 ± 9.3

15/15

31/24

36

17

26

0

IIIB–IV

Kanoh Y [9]

2013

37 (13/24)

62.6 (53–72)

66.2 (52–79)

NA

NA

24

0

0

I-IV

  1. NA unavailable; N cases; LAC lung adenocarcinoma; LSCC lung squamous cell carcinoma; SCLC small cell lung cancer